
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT
- About
Holdco Nuvo Group D.G Ltd. Ordinary Shares (NUVO)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/24/2024: NUVO (1-star) is currently NOT-A-BUY. Pass it for now.
Year Target Price $0
Year Target Price $0
0 | Strong Buy |
0 | Buy |
0 | Hold |
0 | Under performing |
0 | Sell |
Analysis of Past Performance
Type Stock | Historic Profit 5.02% | Avg. Invested days 142 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 5.65M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta -0.41 | 52 Weeks Range 0.00 - 1.23 | Updated Date 06/29/2025 |
52 Weeks Range 0.00 - 1.23 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.01 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) -17524.49% |
Management Effectiveness
Return on Assets (TTM) - | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 39531120 | Price to Sales(TTM) 0.7 |
Enterprise Value 39531120 | Price to Sales(TTM) 0.7 | ||
Enterprise Value to Revenue 63.33 | Enterprise Value to EBITDA - | Shares Outstanding 33261500 | Shares Floating 9927622 |
Shares Outstanding 33261500 | Shares Floating 9927622 | ||
Percent Insiders 39.62 | Percent Institutions 1.44 |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Holdco Nuvo Group D.G Ltd. Ordinary Shares
Company Overview
History and Background
Holdco Nuvo Group D.G Ltd. Ordinary Shares, operating under the symbol NVRO, primarily focuses on medical solutions for women's health. They are known for their Invu by Nuvo system, a remote pregnancy monitoring system. Its history includes research and development in ultrasound technology and commercialization of its innovative monitoring solution.
Core Business Areas
- Remote Pregnancy Monitoring: Develops and markets Invu by Nuvo, a remote fetal monitoring system, aiming to improve prenatal care access and quality. It allows physicians to monitor maternal and fetal heart rates remotely.
Leadership and Structure
The leadership team consists of experienced executives in medical devices and technology. The organizational structure likely involves R&D, marketing, sales, and regulatory affairs departments focused on the Invu system and related technologies.
Top Products and Market Share
Key Offerings
- Invu by Nuvo: A remote pregnancy monitoring system that provides continuous maternal and fetal heart rate monitoring. Its competitors include traditional fetal monitoring devices and other emerging remote monitoring solutions. Market share is still developing as remote monitoring becomes more widely adopted.
Market Dynamics
Industry Overview
The medical device industry, particularly in prenatal care, is experiencing growth driven by technological advancements, increasing maternal age, and a need for improved prenatal care accessibility. The demand for remote monitoring solutions is growing due to convenience and improved data access.
Positioning
Nuvo Group is positioned as an innovator in remote pregnancy monitoring with its Invu system. Its competitive advantage lies in its non-invasive, continuous monitoring capability and user-friendly design.
Total Addressable Market (TAM)
The TAM for remote pregnancy monitoring is estimated in the billions of dollars, globally. Nuvo is positioned to capture a portion of this market as adoption increases.
Upturn SWOT Analysis
Strengths
- Innovative remote monitoring technology
- FDA clearance for Invu system
- Potential to improve prenatal care access
- Proprietary technology
Weaknesses
- Limited market presence
- Reliance on a single product
- Need for reimbursement coverage
- Cash burn rate
Opportunities
- Expanding remote monitoring market
- Partnerships with healthcare providers
- Increased adoption of telehealth
- Potential for international expansion
Threats
- Competition from established medical device companies
- Regulatory hurdles
- Reimbursement challenges
- Technological obsolescence
Competitors and Market Share
Key Competitors
- GE Healthcare (GE)
- Philips (PHG)
- Siemens Healthineers (SMMNY)
Competitive Landscape
Compared to established players like GE and Philips, Nuvo Group faces challenges in terms of market reach and brand recognition. However, it benefits from its focus on remote pregnancy monitoring and innovative technology.
Growth Trajectory and Initiatives
Historical Growth: Limited history as a publicly traded company to show historical growth. Growth depends on the commercial success of Invu.
Future Projections: Future projections are dependent on market acceptance of Invu, regulatory approvals, and reimbursement coverage. Analyst estimates would be crucial for providing specific growth projections.
Recent Initiatives: Recent initiatives likely include expanding sales and marketing efforts, securing reimbursement coverage, and conducting clinical trials to support Invu's effectiveness.
Summary
Nuvo Group, with its Invu system, shows promise in the remote pregnancy monitoring sector, but the company is still relatively small and carries notable financial risks. Key aspects to monitor are sales growth, adoption of reimbursement, expansion of strategic partnerships, and clinical data from ongoing and future trials.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Filings
- Industry Reports
- Analyst Estimates (where available)
Disclaimers:
This analysis is for informational purposes only and should not be considered financial advice. Market share data are estimates and may vary. Future performance is not guaranteed.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Holdco Nuvo Group D.G Ltd. Ordinary Shares
Exchange NYSE MKT | Headquaters - | ||
IPO Launch date 2024-05-01 | CEO & Director Mr. Robert Maurice Powell Jr. | ||
Sector Healthcare | Industry Medical Devices | Full time employees - | Website https://www.nuvocares.com |
Full time employees - | Website https://www.nuvocares.com |
Holdco Nuvo Group D.G Ltd engages in the research, development, and marketing of medical devices for pregnancy monitoring in Israel, the United States, and internationally. It provides INVU platform, a remote pregnancy monitoring platform that provides expectant mothers with a self -administered wireless sensory band, which enables them and their obstetricians to monitor maternal and fetal heart rate, and maternal uterine activity at home and in the clinic from the 32nd week of pregnancy until the beginning of labor. The company's INVU platform includes a wireless sensory band with multi-modality technology to capture signals to enable the INVU platform; and a cloud computing environment that processes and analyzes data and transmits personalized reports on maternal and fetal health metrics to the expectant mother and her obstetrician through digital visualization tools. It has a collaboration with Royal Philips and Charité " Universitätsmedizin Berlin. The company was formerly known as Nuvo Group Ltd. and changed its name to Holdco Nuvo Group D.G Ltd in May 2024. Holdco Nuvo Group D.G Ltd incorporated in 2006 and is headquartered in Tel Aviv, Israel. On August 22, 2024, Holdco Nuvo Group D.G Ltd filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.